what is a natural alternative for glp-1 Nutritional & Botanical Support Activity GLP-1 Medications: Benefits, Risks, and

At present, evidence remains hypothesis-generating, and dedicated mechanistic and disease-specific studies are needed to determine whether GLP-1RAs have clinically meaningful impact on the incidence or progression of AITD

Accessed February 2026.

This stability in risk ratios translates into a steadily growing absolute risk difference from one to three years

Additionally, GIPR antagonists also exhibit improvement of metabolism on obese mice 57 and GIPR agonists or antagonists both show therapeutical effects in combination with GLP-1R agonists

Still, the analysts predicted that Ozempic, Wegovy, and Rybelsus (semaglutide) maker Novo Nordisk and Eli Lilly, which developed Zepbound and Mounjaro (tirzepatide), will maintain two-thirds of the market by 2031 due to their first-mover advantages. Other competitors are expected to take a combined $70 billion of the GLP-1 market, the study read